# Hirofumi Makino

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hirofumi-makino/

## Facts

| Field | Value |
| --- | --- |
| Citations | 38,753 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 89 |
| i10-index | 496 |
| Last Known Institution | Okayama University Hospital |
| OpenAlex ID | https://openalex.org/A5101668258 |
| ORCID iD | 0000-0002-1559-3799 |
| Works | 980 |

## Researcher papers

Showing 12 of 23.

- [The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited](https://scholariq.org/papers/the-classification-of-glomerulonephritis-in-systemic-lupus-erythematosus/)
- [The classification of glomerulonephritis in systemic lupus erythematosus revisited](https://scholariq.org/papers/the-classification-of-glomerulonephritis-in-systemic-lupus-erythematosus-2/)
- [Inflammation and the pathogenesis of diabetic nephropathy](https://scholariq.org/papers/inflammation-and-the-pathogenesis-of-diabetic-nephropathy/)
- [Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin system](https://scholariq.org/papers/uric-acid-stimulates-vascular-smooth-muscle-cell-proliferation-and-oxidative/)
- [Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity](https://scholariq.org/papers/visceral-adipose-tissue-derived-serine-protease-inhibitor-a-unique-insulin/)
- [Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/atrasentan-and-renal-events-in-patients-with-type-2-diabetes-and-chronic-kidney/)
- [Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease](https://scholariq.org/papers/estimation-of-glomerular-filtration-rate-by-the-mdrd-study-equation-modified-for/)
- [Prevalence of chronic kidney disease in the Japanese general population](https://scholariq.org/papers/prevalence-of-chronic-kidney-disease-in-the-japanese-general-population/)
- [Proposal for diagnostic criteria for IgG4-related kidney disease](https://scholariq.org/papers/proposal-for-diagnostic-criteria-for-igg4-related-kidney-disease/)
- [Innate immunity in diabetes and diabetic nephropathy](https://scholariq.org/papers/innate-immunity-in-diabetes-and-diabetic-nephropathy/)
- [Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial](https://scholariq.org/papers/febuxostat-therapy-for-patients-with-stage-3-ckd-and-asymptomatic-hyperuricemia/)
- [Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials](https://scholariq.org/papers/change-in-albuminuria-as-a-surrogate-endpoint-for-progression-of-kidney-disease/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

## Researcher university

- [Okayama University Hospital](https://scholariq.org/institutions/okayama-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.